Neoadjuvant Therapy of DOF Regimen Plus Bevacizumab Can Increase Surgical Resection Ratein Locally Advanced Gastric Cancer

Title
Neoadjuvant Therapy of DOF Regimen Plus Bevacizumab Can Increase Surgical Resection Ratein Locally Advanced Gastric Cancer
Authors
Keywords
-
Journal
MEDICINE
Volume 94, Issue 42, Pages e1489
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2015-10-24
DOI
10.1097/md.0000000000001489

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation